Floatz logo

Bendamustine

Progesterone Receptor Positive

National Cancer Institute (NCI)Small moleculePhase 2Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Progesterone Receptor Positive cohort.

Asset / SponsorPhaseRating
Inno-206
City of Hope Medical Center
Phase 3BB
Letrozole
Emory University
Phase 2BB
TRASTUZUMAB
M.D. Anderson Cancer Center
Phase 3BB
Cyclophosphamide
City of Hope Medical Center
Phase 3BB
FULVESTRANT
Emory University
Phase 3BB

View all 32 →

Same molecule, other indications

Bendamustine is also rated in:

mantle cell lymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
73 / 100
View asset →
diffuse large B-cell lymphomaDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →